Concordant induction of 15-lipoxygenase-1 and mutant p53 expression in human prostate adenocarcinoma: Correlation with Gleason staging

Carcinogenesis

Volumn 21, Issue 10, 2000, Pages 1777-1787

  Kelavkar, Uddhav P ^b   Cohen, Cynthia ^b   Kamitani, Hideki ^c   Eling, Thomas E ^c   Badr, Kamal F ^a  

^a EMORY UNIVERSITY   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONATE 15 LIPOXYGENASE; CORIOLIC ACID; LINOLEIC ACID; MUTANT PROTEIN; PROTEIN P53;

ARTICLE; BASAL CELL; CANCER GRADING; CANCER LOCALIZATION; CANCER STAGING; CHIRALITY; CONTROLLED STUDY; ENZYME LOCALIZATION; ENZYME SUBSTRATE; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; NEEDLE BIOPSY; NUCLEOTIDE SEQUENCE; PATHOLOGY; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROSTATECTOMY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SECRETORY CELL; SEMINAL VESICLE; STROMA; TRANSURETHRAL RESECTION; TUMOR SUPPRESSOR GENE; WESTERN BLOTTING;

ADENOCARCINOMA; ARACHIDONATE 15-LIPOXYGENASE; ARACHIDONIC ACID; BLOTTING, WESTERN; ENZYME INDUCTION; HUMANS; IMMUNOHISTOCHEMISTRY; LINOLEIC ACID; LINOLEIC ACIDS; MALE; MUTATION; NEOPLASM STAGING; PROSTATIC NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STEREOISOMERISM; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0033783018     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (67)

1. Interleukin 1-induced cancer cell/endothelial cell adhesion in vitro and its relationship to metastasis in vivo: Role of vessel wall 13-HODE synthesis and integrin expression
2. Regulation of endothelial cell and platelet receptor-ligand binding by the 12- and 15-lipoxygenase monohydroxides, 12-, 15-HETE and 13-HODE
3. Expression of 15-lipoxygenase-1 in human colorectal cancer
4. Expression of 15-lipoxygenase by human colorectal carcinoma Caco-2 cells during apoptosis and cell differentiation
5. Role of lipoxygenases in breast cancer
6. Characterization of a 15-lipoxygenase in human breast carcinoma BT-20 cells: Stimulation of 13-HODE formation by TGF alpha/EGF
7. Opposite effects of linoleic acid and conjugated linoleic acid on human prostatic cancer in SCID mice
8. Linoleic acid intake and cancer risk: A review and meta-analysis
9. Dietary fat and advanced prostate cancer
10. Specific fatty acids and risks of breast and prostate cancer: Dietary intake
11. The role of linoleic acid metabolism in the proliferative response of cells overexpressing the erbB-2/HER2 oncogene
12. New actions of melatonin on tumor metabolism and growth
13. Decrease in linoleic acid metabolites as a potential mechanism in cancer risk reduction by conjugated linoleic acid
14. Influence of dietary linoleic acid on experimental human breast cancer cell metastasis in athymic nude mice
15. Aspirin and the potential role of prostaglandins in colon cancer
16. Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2
17. Alteration of the tumor suppressor gene p53 in a high fraction of hormone refractory prostate cancer
18. p53 alteration in regional lymph node metastases from prostate carcinoma: A marker for progression?
19. Association of p53 immunoreactivity with high Gleason tumor grade in prostatic adenocarcinoma
20. p53 tumor suppressor gene mutations in benign prostatic hyperplasia and prostate cancer
21. Effects of mutant p53 expression on human 15-lipoxygenase-promoter activity and murine 12/15-lipoxygenase gene expression: Evidence that 15-lipoxygenase is a mutator gene
22. Leukotrienes and lipoxins: Structures, biosynthesis and biological effects
23. Elevated 12-lipoxygenase mRNA expression correlates with advanced stage and poor differentiation of human prostate cancer
24. Arachidonic acid stimulates prostate cancer cell growth: Critical role of 5-lipoxygenase
25. 15-Lipoxygenase-2 (15-LOX-2) is expressed in benign prostatic epithelium and reduced in prostate adenocarcinoma
26. 12-Lipoxygenase, 12(S)-HETE and cancer metastasis
27. Tumor derived 12(S)-hydroxyeicosatetraenoic acid induces microvascular endothelial cell retraction
28. Endogenous 12-S-HETE production by tumor cells and its role in metastasis
29. Platelet-type 12-lipoxygenase in a human prostate carcinoma stimulates angiogenesis and tumor growth
30. Inhibition of arachidonate 5-lipoxygenase triggers massive apoptosis in human prostate cancer cells
31. 5-Lipoxygenase inhibitors reduce PC-3 cell proliferation and initiate nonnecrotic cell death
32. Production of 13-hydroxyoctadecadienoic acid (13-HODE) by prostate tumors and cell lines
33. Different patterns of p53 mutations in prostatic intraepithelial neoplasia and concurrent carcinoma: Analysis of microdissected specimens
34. P53 immunoreactivity as prognostic marker for cancer-specific survival in prostate cancer
35. Immunocytochemical localization of arachidonate 15-lipoxygenase in erythrocytes, leukocytes and airway cells
36. The expression of 15-lipoxygenase gene and the presence of functional enzyme in cytoplasm and nuclei of pregnancy human myometria
37. Image cytometric measurement of nuclear proliferation markers (MIB-1, PCNA) in astrocytomas. Prognostic significance
38. Immunohistochemical p53 in hepatocellular carcinoma and liver cell dysplasia
39. The prognostic significance of proliferation in prostate cancer
40. Ku autoantigen (DNA helicase) is required for interleukins-13/-4-induction of 15-lipoxygenase-1 gene expression in human epithelial cells
41. Interleukin-4 and interleukin-13: Their similarities and discrepancies
42. Interleukin-13 suppresses cytokine production and stimulates the production of 15-HETE in PBMC. A comparison between IL-4 and IL-13
43. Interleukin-13 receptors on human prostate carcinoma cell lines represent a novel target for a chimeric protein composed of IL-13 and a mutated form of Pseudomonas exotoxin
44. Induction of 15-lipoxygenase by interleukin-13 in human blood monocytes
45. Adenovirus-mediated p53 gene therapy has greater efficacy when combined with chemotherapy against human head and neck, ovarian, prostate and breast cancer
46. 12(S)-Hydroxyeicostetraenoic acid and 13(S)-hydroxyoctadecadienoic acid regulation of protein kinase C in melanoma cells: Role of receptor-mediated hydrolysis of inositol phospholipids
47. 13-Hydroxyoctadecadienoic acid is the mitogenic signal for linoleic acid-dependent growth in rat hepatoma 7288CTC in vivo
48. Effects of reduced dietary linoleic acid intake, alone or combined with an algal source of docosahexaenoic acid, on MDA-MB-231 breast cancer cell growth and apoptosis in nude mice
49. Eicosanoids as mediators of linoleic acid-stimulated invasion and type IV collagenase production by a metastatic human breast cancer cell line
50. Effects of fatty acids and eicosanoid synthesis inhibitors on the growth of two human prostate cancer cell lines
51. Effects of dietary fatty acids on DU145 human prostate cancer cell growth in athymic nude mice
52. Opposite effects of linoleic acid and conjugated linoleic acid on human prostatic cancer in SCID mice
53. A prospective study of dietary fat and risk of prostate cancer
54. Selective incorporation of (15S)-hydroxyeicosatetraenoic acid in phosphatidylinositol of human neutrophils: Agonist-induced deacylation and transformation of stored hydroxyeicosanoids
55. Lipoxin A4 antagonizes cellular and in vivo actions of leukotriene D4 in rat glomerular mesangial cells: Evidence for competition at a common receptor
56. Fifteen-S-hydroxyeicosatetraenoic acid (15-S-HETE) specifically antagonizes the chemotactic action and glomerular synthesis of leukotriene B4 in the rat
57. Lipoxygenase product formation and cell adhesion during neutrophil-glomerular endothelial cell interaction
58. Substitution of 15-hydroxyeicosatetraenoic acid in the phosphoinositide signaling pathway
59. Remodeling of neutrophil phospholipids with 15(S)-hydroxyeicosatetraenoic acid inhibits leukotriene B4-induced neutrophil migration across endothelium
60. 15-Hydroxyeicosatetraenoic acid inhibits neutrophil migration across cytokine-activated endothelium
61. Neutrophil-mediated changes in vascular permeability are inhibited by topical application of aspirin-triggered 15-epi-lipoxin A4 and novel lipoxin B4 stable analogues
62. Aspirin-triggered 15-epi-lipoxin A4 (LXA4) and LXA4 stable analogues are potent inhibitors of acute inflammation: Evidence for anti-inflammatory receptors
63. Identification of a human enterocyte lipoxin A4 receptor that is regulated by interleukin (IL)-13 and interferon and inhibits tumor necrosis factor-induced IL-8 release
64. Growth inhibition of human prostate cells in vitro by novel inhibitors of androgen synthesis
65. Angiotensin II activation of insulin-like growth factor 1 receptor transcription is mediated by a tyrosine kinase-dependent redox-sensitive mechanism
66. Linoleic acid and its metabolites, hydroperoxyoctadecadienoic acids, stimulate c-Fos, c-Jun and c-Myc mRNA expression, mitogen-activated protein kinase activation and growth in rat aortic smooth muscle cells
67. Transfection of rat kidney with human 15-lipoxygenase suppresses inflammation and preserves function in experimental glomerulonephritis